Keyphrases
Advanced Disease
14%
Advanced Squamous Cell Carcinoma
14%
Apoptosis Inhibition
14%
B-cell Lymphoma 2 (Bcl-2)
100%
Bcl-2 Expression
100%
Bcl-xL
100%
Cancer Development
14%
Clinical Outcomes
28%
Combined Modality Therapy
14%
Common Mechanisms
14%
Disease-specific Survival
28%
Enhanced Expression
14%
Formalin-fixed Paraffin-embedded Tissue
14%
Gene Products
14%
Head-and-neck
100%
Immunohistochemistry
14%
Inhibitor of Apoptosis Proteins
28%
Less Toxic
14%
Locally Advanced
14%
Locoregionally Advanced
14%
Normal Epithelium
14%
Oncogenesis
14%
Overall Survival
14%
Overexpression
14%
P53 Expression
14%
P53 Gene
14%
Pretreatment Biopsy
14%
Programmed Cell Death
14%
Response to Therapy
14%
Squamous Cell Carcinoma of Head
100%
Therapeutic Responsiveness
14%
Tumor
57%
Tumor Biopsy
14%
Medicine and Dentistry
Antibodies
25%
Biopsy
25%
Carcinogenesis
25%
Disease
25%
Disease Specific Survival
50%
Formaldehyde
25%
Gene Product
25%
Immunohistochemistry
25%
Malignant Neoplasm
25%
Multimodality Cancer Therapy
25%
Neck
100%
Neoplasm
100%
Overall Survival
25%
Programmed Cell Death
50%
Protein P53
75%
Squamous Cell Carcinoma
100%
Tumor Biopsy
25%
Pharmacology, Toxicology and Pharmaceutical Science
Antibodies
20%
Carcinogenesis
20%
Disease
20%
Disease Specific Survival
40%
Formaldehyde
20%
Malignant Neoplasm
20%
Neoplasm
100%
Overall Survival
20%
Programmed Cell Death
20%
Protein P53
60%
Squamous Cell Carcinoma
100%
Neuroscience
Antibodies
12%
Bcl-2
100%
Carcinogenesis
12%
Cell Death
12%
Gene Product
12%
Immunohistochemistry
12%
P53
37%